August, 2021
KINECT-HD2: Rollover Study of Valbenazine for Chorea in HD
Posted on August 26, 2021
KINECT-HD2, the open-label extension of KINECT-HD, is seeking 30 new participants to join a study of valbenazine for chorea in Huntington’s disease….
Read MoreHDBuzz on Recent News in the HD Research Pipeline
Posted on August 19, 2021
The August 9th press release from Voyager Therapeutics left many of us scratching our heads. Luckily, HDBuzz swooped in with their latest…
Read MoreVoyager Therapeutics Shifts Directions
Posted on August 12, 2021
Voyager Therapeutics issued a press release on Monday about their finances, recent leadership transitions, and importantly, a major shift in their…
Read MoreHD Parity Act and Pro-Patient Advocacy in the Neurological Disease Community
Posted on August 5, 2021
Last week, Kala Booth, a Huntington’s disease patient, caregiver, advocate, and the 4th known generation in her family to test HD positive appeared before the House…
Read More